• Citer

PSA evolution: a prognostic factor during treatment of advanced prostatic carcinoma with total androgen blockade: Data from a Belgian multicentric study of 546 patients

par Oosterlinck, W;Mattelaer, J;Casselman, Jan W.;Van Velthoven, Roland ;Derde, Marie Paule;Kaufman, L.
Référence Acta urologica Belgica, 65, 3, page (63-71)
Publication Publié, 1997-10

Article révisé par les pairs

• Détails
• Contenu

Titre:	PSA evolution: a prognostic factor during treatment of advanced prostatic carcinoma with total androgen blockade: Data from a Belgian multicentric study of 546 patients
Auteur:	Oosterlinck, W; Mattelaer, J; Casselman, Jan W.; Van Velthoven, Roland; Derde, Marie Paule; Kaufman, L.
Informations sur la publication:	Acta urologica Belgica, 65, 3, page (63-71)
Statut de publication:	Publié, 1997-10
Sujet CREF:	Sciences bio-médicales et agricoles
MeSH keywords:	Aged
	Analysis of Variance
	Androgen Antagonists -- therapeutic use
	Antineoplastic Agents, Hormonal -- therapeutic use
	Belgium
	Carcinoma -- drug therapy -- pathology -- secondary -- surgery
	Disease Progression
	Disease-Free Survival
	Flutamide -- administration & dosage -- therapeutic use
	Follow-Up Studies
	Gonadotropin-Releasing Hormone -- analogs & derivatives
	Health Status
	Humans
	Male
	Multivariate Analysis
	Neoplasm Staging
	Orchiectomy
	Pain -- physiopathology
	Prognosis
	Prostate-Specific Antigen -- blood
	Prostatic Neoplasms -- drug therapy -- pathology -- surgery
	Regression Analysis
	Safety
	Survival Rate
	Urination Disorders -- physiopathology
Langue:	Anglais
Identificateurs:	urn:issn:0001-7183
	info:scp/0030659642
	info:pmid/9421938